Status:
COMPLETED
Stop Tip-toeing Around Toe-walking
Lead Sponsor:
University Children's Hospital Basel
Conditions:
Spastic Cerebral Palsy (sCP)
Eligibility:
All Genders
7-18 years
Phase:
NA
Brief Summary
The purpose of this study is to explore the interplay among nervous-, musculoskeletal-, and psychological systems and how they impact toe-walking behavior, and vice versa. Sub-Project 1 is to analyze...
Detailed Description
The interplay between the nervous-, musculoskeletal-, and psychological systems and their impact on resulting walking patterns are poorly understood. Children that toe-walk often show poorer levels of...
Eligibility Criteria
Inclusion
- Inclusion Criteria for TD children:
- between the age of 7 and 18 years
- who are typically developing
- able to stand and walk alone without using assistance or assistive devices
- able to place their feet flat on the force platforms
- with enough German language skills to follow the instructions
- Inclusion Criteria for sCP children:
- between the age of 7 and 18 years
- with the diagnosis of spastic CP or CP similar (both unilateral and bilateral), functionally classified level I or II according to the Gross Motor Function Classification System (GMFCS)
- being able to stand and walk alone without assistance or assistive devices
- able to place their feet flat on the force platforms
- with enough German language skills to follow the instructions
- Exclusion Criteria for TD children:
- severe visual, cognitive, or auditory impairments that would interfere with the study instructions and the VR immersion
- any vestibular problems (e.g. severe motion sickness)
- history of epilepsy, pace-marker or/and electrical pumps (due to possible interference with electrical stimulation)
- prior experience of VR to ensure a comparable baseline between subjects
- Exclusion Criteria for sCP children:
- severe visual, cognitive, or auditory impairments that would interfere with the study instructions and the VR immersion
- severe knee flexion gait (\>45°)
- walking capacity \<50m
- botulinum toxin type A treatment (past 6 months)
- orthopedic surgery of upper or lower extremities (past 12 months)
- any vestibular problems (e.g. severe motion sickness or dizziness)
- history of epilepsy, pace-marker or/and electrical pumps (due to possible interference with electrical stimulation)
- prior experience of VR as they may already be adapted to VR.
Exclusion
Key Trial Info
Start Date :
August 11 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2023
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04879199
Start Date
August 11 2021
End Date
September 30 2023
Last Update
October 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Children's Hospital Basel, Neuroorthopedics I Human Locomotion Research
Basel, Switzerland, 4056